Testosterone to Estradiol Ratio (T/E2) Calculator

Testosterone to Estradiol Ratio (T/E2) Calculator for Endocrinology. A low T/E2 ratio flags relative estrogen excess, driven by higher aromatase activity (typically in adiposity), and is the pattern seen with gynecomastia, low libido, and mood symptoms despite testosterone that may look borderline normal. A high ratio, common on an aromatase inhibitor, warns of estrogen suppression that can impair bone density, lipids, and libido, since estradiol is essential to male bone and sexual function. The ratio is best used as a directional signal to prompt weight-loss counseling, dose adjustment of an aromatase inhibitor, or reassessment of estradiol on testosterone therapy, rather than as a hard cutoff. There is no society-endorsed target value.

How this calculator works

The calculator divides serum total testosterone by serum estradiol after forcing both into the same molar or mass frame, since the two are almost always reported in different units. The cleanest approach converts testosterone from ng/dL to pg/mL (multiply by 10) so both hormones share pg/mL, then divides T by E2; some labs instead express both in pmol/L. Because of the unit mismatch, a raw ratio is meaningless unless the tool states its convention, so always read off the displayed units. The output is a single unitless index summarizing the balance between the primary androgen and its aromatized estrogen product.

When to use this calculator

This ratio is used mainly in men being evaluated or managed for hypogonadism, gynecomastia, obesity-related hypogonadotropic hypogonadism, or subfertility, and to monitor men on aromatase inhibitors (anastrozole, letrozole) or on testosterone therapy where estradiol may rise. It helps decide whether a symptom picture reflects relative estrogen excess rather than an isolated low testosterone. It should not be used in women, children, or pubertal boys, and it is not a diagnostic threshold for hypogonadism on its own, the Endocrine Society bases that diagnosis on symptoms plus repeated low morning total testosterone, not on an estradiol ratio.

Inputs used

  • Testosterone
  • Estradiol
  • Unit conversion

Clinical interpretation

A low T/E2 ratio flags relative estrogen excess, driven by higher aromatase activity (typically in adiposity), and is the pattern seen with gynecomastia, low libido, and mood symptoms despite testosterone that may look borderline normal. A high ratio, common on an aromatase inhibitor, warns of estrogen suppression that can impair bone density, lipids, and libido, since estradiol is essential to male bone and sexual function. The ratio is best used as a directional signal to prompt weight-loss counseling, dose adjustment of an aromatase inhibitor, or reassessment of estradiol on testosterone therapy, rather than as a hard cutoff. There is no society-endorsed target value.

Worked example

A 46-year-old man with low libido and mild gynecomastia has total testosterone 350 ng/dL and estradiol 45 pg/mL. Converting testosterone to pg/mL gives 3500 pg/mL, so T/E2 = 3500 / 45 = about 78 (pg/mL basis). That figure sits below the commonly cited healthy male band of roughly 10 to 30 when both are in ng/dL and pg/mL respectively... note that the exact "normal" range depends entirely on which unit convention the tool applies, so the number is only interpretable against the same-convention reference the calculator displays.

Limitations and safety notes

The ratio has never been prospectively validated as a diagnostic threshold, and reference ranges vary widely between publications because of differing units and assays. Estradiol in men is low and must be measured by a sensitive liquid chromatography-tandem mass spectrometry assay; standard immunoassays overestimate low male estradiol and can distort the ratio badly. The metric is meaningless in women, children, and pubertal boys, and it does not account for SHBG or free hormone fractions, so two men with identical ratios can have very different bioavailable hormone status.

Frequently asked questions

What is a normal testosterone to estradiol ratio in men?

There is no universally agreed value. Frequently cited healthy ranges cluster around 10 to 30 when testosterone is in ng/dL and estradiol in pg/mL, but the number is only meaningful against the specific unit convention and reference range the calculator displays, and no endocrine society has endorsed a diagnostic cutoff.

Should I trust the ratio if estradiol was measured by immunoassay?

Be cautious. Male estradiol is low and standard immunoassays tend to overestimate it, which inflates the denominator and lowers the ratio. A sensitive LC-MS/MS estradiol assay is strongly preferred before acting on the number.

Does a low ratio mean I need an aromatase inhibitor?

Not automatically. A low ratio suggests relative estrogen excess, but the Endocrine Society does not recommend aromatase inhibitors as routine therapy for hypogonadism. Weight loss, reviewing testosterone dosing, and confirming the estradiol assay usually come first.

Why do I need to check the units before reading the result?

Testosterone and estradiol are almost always reported in different units, so the ratio changes by a factor of ten or more depending on whether the tool works in ng/dL, pg/mL, or pmol/L. Always match your result to the reference range in the same convention.

Can this ratio be used in women?

No. This tool and its reference bands apply to adult men. In women, children, and pubertal boys the physiology and normal estradiol levels are entirely different, and the ratio has no established interpretation.

References

  • Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018. PMID: 29562364.
  • Tan RBW, Guay AT, Hellstrom WJG. Clinical Use of Aromatase Inhibitors in Adult Males. Sex Med Rev. 2015. PMID: 27784593.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: June 3, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators